TIMOTHY D. VEENSTRA, PhD, is Director of the Laboratory of Proteomics and Analytical Technologies at the Frederick National Laboratory for Cancer Research. Dr. Veenstra and his lab group develop and apply chromatography and mass spectrometry approaches to characterize protein complexes and the role of post-translational modifications in these complexes. Additionally, they use high-throughput proteomic approaches for the discovery of biomarkers for disease as well as proteomic and metabolomic technology for the interrogation of clinical samples. Dr. Veenstra has coauthored more than 300 peer-reviewed publications and is the coeditor of Proteomics for Biological Discovery.

“By guiding readers through the latest proteomic technologies and their applications in cancer research, “Proteomic Applications in Cancer Detection and Discovery" enhances the ability of researchers in proteomics and researchers in oncology to collaborate in order to better understand cancer and develop strategies to prevent and treat it.”  (Newbooks.lib, 11 September 2014

• Preface viiAcknowledgments ix1 Systems Biology 12 Mass Spectrometry in Cancer Research 273 Quantitative Proteomics 594 Proteomic Analysis of Posttranslational Modifications 875 Characterization of Protein Complexes 1176 Global Phosphorylation Analysis 1457 the Search for Biomarkers in Biofluids 1718 Proteomic Patterns: a New Paradigm in Diagnostics And Therapeutics? 1959 the Emergence of Protein Arrays 21510 the Role of Proteomics in Personalized Medicine 24111 the Critical Role of Bioinformatics 26312 Future Prospects of Proteomics in Cancer Research 281Index 305

TIMOTHY D. VEENSTRA, PhD, is Director of the Laboratory of Proteomics and Analytical Technologies at the Frederick National Laboratory for Cancer Research. Dr. Veenstra and his lab group develop and apply chromatography and mass spectrometry approaches to characterize protein complexes and the role of post-translational modifications in these complexes. Additionally, they use high-throughput proteomic approaches for the discovery of biomarkers for disease as well as proteomic and metabolomic technology for the interrogation of clinical samples. Dr. Veenstra has coauthored more than 300 peer-reviewed publications and is the coeditor of Proteomics for Biological Discovery.

“By guiding readers through the latest proteomic technologies and their applications in cancer research, “Proteomic Applications in Cancer Detection and Discovery" enhances the ability of researchers in proteomics and researchers in oncology to collaborate in order to better understand cancer and develop strategies to prevent and treat it.”  (Newbooks.lib, 11 September 2014

• Preface viiAcknowledgments ix1 Systems Biology 12 Mass Spectrometry in Cancer Research 273 Quantitative Proteomics 594 Proteomic Analysis of Posttranslational Modifications 875 Characterization of Protein Complexes 1176 Global Phosphorylation Analysis 1457 the Search for Biomarkers in Biofluids 1718 Proteomic Patterns: a New Paradigm in Diagnostics And Therapeutics? 1959 the Emergence of Protein Arrays 21510 the Role of Proteomics in Personalized Medicine 24111 the Critical Role of Bioinformatics 26312 Future Prospects of Proteomics in Cancer Research 281Index 305

TIMOTHY D. VEENSTRA, PhD, is Director of the Laboratory of Proteomics and Analytical Technologies at the Frederick National Laboratory for Cancer Research. Dr. Veenstra and his lab group develop and apply chromatography and mass spectrometry approaches to characterize protein complexes and the role of post-translational modifications in these complexes. Additionally, they use high-throughput proteomic approaches for the discovery of biomarkers for disease as well as proteomic and metabolomic technology for the interrogation of clinical samples. Dr. Veenstra has coauthored more than 300 peer-reviewed publications and is the coeditor of Proteomics for Biological Discovery.

“By guiding readers through the latest proteomic technologies and their applications in cancer research, “Proteomic Applications in Cancer Detection and Discovery" enhances the ability of researchers in proteomics and researchers in oncology to collaborate in order to better understand cancer and develop strategies to prevent and treat it.”  (Newbooks.lib, 11 September 2014

• Preface viiAcknowledgments ix1 Systems Biology 12 Mass Spectrometry in Cancer Research 273 Quantitative Proteomics 594 Proteomic Analysis of Posttranslational Modifications 875 Characterization of Protein Complexes 1176 Global Phosphorylation Analysis 1457 the Search for Biomarkers in Biofluids 1718 Proteomic Patterns: a New Paradigm in Diagnostics And Therapeutics? 1959 the Emergence of Protein Arrays 21510 the Role of Proteomics in Personalized Medicine 24111 the Critical Role of Bioinformatics 26312 Future Prospects of Proteomics in Cancer Research 281Index 305